Viewing Study NCT04465266


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-25 @ 2:27 PM
Study NCT ID: NCT04465266
Status: COMPLETED
Last Update Posted: 2022-02-01
First Post: 2020-07-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 PK Study of Tolperisone in Healthy Subjects
Sponsor: Neurana Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module